92102-83-5

Usage

InChI:InChI=1/C14H11ClN2O3/c15-12-7-6-11(8-13(12)17(19)20)14(18)16-9-10-4-2-1-3-5-10/h1-8H,9H2,(H,16,18)

Upstream product

• 100-46-9 benzylamine 
• 38818-50-7 4-chloro-3-nitro-benzoyl chloride 

Downstream Products

• 1386981-79-8 N-(5-benzylcarbamoyl-2-chloro-phenyl)-malonamic acid methyl ester 
• 1386980-46-6 2-(4-methyl-piperazin-1-yl)-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid (5-benzylcarbamoyl-2-chloro-phenyl)-amide 
• 1386979-19-6 2-Methoxy-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid (5-benzylcarbamoyl-2-chloro-phenyl)-amide 

Relevant academic research and scientific papers

CARBOXYLIC ACID ARYL AMIDES

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer.

PYRIDO PYRIMIDINES

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.